Advanced Therapeutics – from Nano‐Vaccines to Immunotherapies

In this editorial, we would like to share some news around the journal and our community. First foremost, are excited announce that Advanced Therapeutics has now been accepted into Web of Science: Science Citation Index Expanded (category: Pharmacology & Pharmacy). This means will receive its highly-anticipated first 2 year-Impact Factor (JCR, Clarivate Analytics) in 2022. addition, is also indexed by Scopus Embase (Elsevier). Our authors readers therefore enjoy increased discoverability published science – which vital, especially for a focused on translational biomedical field. Topic-wise most noticed themes were linked gut inflammatory disease, infectious diseases course cancer treatment. Table 1 lists those topics, as measured being picked up social media sites. They reflected issue cover images (see Figure 1) helping illustrate highlight top papers from issues. August have an exciting new Special Issue *Next Generation Immunotherapies* guest edited James Moon (University Michigan, US), Bruno de Geest (Ghent University, Belgium) Xun Sun (Sichuan China). The collects 9 reviews 12 research articles topics immune modulation use strategies against cancer, beyond. At beginning year, Hélder Santos (Groningen, Netherlands), Christian Celia Chieti Pescara “G. d'Annunzio”, Italy) Donatella Paolino Catanzaro “Magna Graecia”, guest-edited “Advanced Nanosystems Clinical Translation”. collection was based 1st International Northern-Southern Europe Workshop Nanomedicine held Chieti, Italy, early 2020. We express gratitude your interest Therapeutics, editorial board members, authors, last but not least, readers. Wishing you peaceful, joyful, successful, healthy Year New year wishes, at turn 2021, complete without adding special nod COVID-19. While indispensable managing pandemic provides us with clear route overcome it, countries again heavily impacted virus. hope you, family, friends stay safe during these challenging times. team